What is TransMedics Group Inc (TMDX)?
TransMedics Group Inc is a medical technology company specializing in the development and commercialization of organ transplant systems. The company focuses on innovative solutions designed to improve the preservation, assessment, and transportation of donor organs. Its flagship technology includes ex vivo organ perfusion systems that maintain organs in a near-physiological state outside the body, potentially increasing the viability and availability of organs for transplantation. TransMedics serves healthcare providers and transplant centers, aiming to address challenges associated with organ shortages and transplantation outcomes. The company's products are used primarily in the management of heart, lung, and kidney transplants. Founded with a mission to enhance the organ transplant process, TransMedics integrates advanced biomedical engineering and clinical research to support transplant teams worldwide. Its operations encompass research and development, regulatory affairs, and global distribution of its medical devices. The company contributes to the field of transplant medicine by enabling better organ preservation and assessment techniques.
TransMedics Group Inc Stock Price Today: Live Overview
The price today is shaped by active market trading, as TransMedics Group Inc holds at $124.76. Its price has fluctuated between $123.45 and $127.98, with a daily percent change of -0.3048%.
FAQ: TransMedics Group Inc (TMDX)
What is the current price of TMDX stock?
TransMedics Group Inc is currently priced at $124.76.
Does TMDX pay dividends?
TransMedics Group Inc does not pay dividends.
Does TMDX have a formal corporate presence or regional headquarters in the UAE?
TransMedics Group Inc operates in the UAE via partners and distributors without an official regional office or subsidiary.
What is TMDX best known for?
TransMedics Group Inc is most famous for its organ transplant technology.
What assets are typically shown together with TMDX?
Commonly shown alongside TMDX: Camtek Ltd/Israel, Bruker Corp, Olympus Corporation
Latest shares articles



